ABSTRACT
Introduction Access port closure might be one example of future transcatheter valve therapies’ (TCVT) evolvements and will contribute to make the transapical direct access valve replacement (DAVR) become a fully percutaneous procedure.
Introduction Access port closure might be one example of future transcatheter valve therapies’ (TCVT) evolvements and will contribute to make the transapical direct access valve replacement (DAVR) become a fully percutaneous procedure.